Author Response for "use of Dipeptidyl Peptidase-4 Inhibitors and Prognosis of COVID-19 in Hospitalized Patients with Type 2 Diabetes: a Propensity Score Analysis from the CORONADO Study" Ronan Roussel , Patrice Darmon , Matthieu Pichelin , Thomas Goronflot , Yawa Abouleka , Leila Ait Bachir , Ingrid Allix , Deborah Ancelle , Sara Barraud , Lyse Bordier , Aurelie Carlier , Nicolas Chevalier , Christine Coffin-Boutreux , Emmanuel Cosson , Anne Dorange , Olivier Dupuy , Pierre Fontaine , Benedicte Fremy , Florence Galtier , Natacha Germain , Anne-Marie Guedj , Etienne Larger , Stephanie Laugier-Robiolle , Bruno Laviolle , Lisa Ludwig , Arnaud Monier , Nathanaelle Montanier , Philippe Moulin , Isabelle Moura , Gaetan Prevost , Yves Reznik , Nadia Sabbah , Pierre-Jean Saulnier , Pierre Serusclat , Camille Vatier , Matthieu Wargny , Samy Hadjadj , Pierre Gourdy , Bertrand Cariou Diabetes, Obesity and Metabolism（2021）
Key words
Dipeptidyl Peptidase-4 Inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
